Related Experiment Videos
Alarmins: awaiting a clinical response
James K Chan1, Johannes Roth, Joost J Oppenheim
1Kennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom. james.chan@kennedy.ox.ac.uk
The Journal of Clinical Investigation
|August 2, 2012
Summary
Alarmins are immune-activating molecules released during tissue damage. While excessive release fuels inflammation and cancer, they also play crucial roles in tissue repair and homeostasis.
Area of Science:
- Immunology
- Molecular Biology
- Pathology
Background:
- Alarmins are endogenous molecules released upon tissue damage, activating the immune system.
- Dysregulated alarmin release is implicated in inflammatory diseases, autoimmune conditions, and cancer progression.
- Conversely, alarmins are vital for tissue homeostasis, repair, and remodeling in various organs.
Purpose of the Study:
- To provide an updated overview of alarmins.
- To highlight the dual role of alarmins in disease and homeostasis.
- To identify potential areas for clinical translation of alarmin-based therapies.
Main Methods:
- Literature review and synthesis of current evidence on alarmins.
- Analysis of alarmin involvement in inflammatory, autoimmune, and oncogenic processes.
- Examination of alarmin functions in tissue repair and remodeling.
Main Results:
- Alarmins exhibit context-dependent roles, acting as both drivers of pathology and mediators of repair.
- Uncontrolled alarmin release contributes to chronic inflammation and cancer.
- Alarmins are essential for maintaining tissue integrity and facilitating healing.
Conclusions:
- Alarmins represent a critical link between tissue damage, immune response, and disease.
- Understanding alarmin biology is key to developing novel therapeutic strategies.
- Clinical translation of alarmin research holds significant promise for treating various conditions.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:29Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
01:27Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:30Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...